Brief: Biofrontera Statement On The Open Letter Of Maruho Deutschland

Biofrontera AG

04/04/2022 11:11

April 4 (Reuters) - BIOFRONTERA AG  B8FGn.DE :
    * AUTHORIZATION TO ISSUE CONVERTIBLE BONDS AND/OR BONDS WITH
WARRANTS PROPOSED TO ANNUAL GENERAL MEETING UNDER AGENDA ITEM 1
AND PROPOSED ORDINARY CAPITAL INCREASE UNDER AGENDA ITEM 2 ARE
IN AN ALTERNATIVE RELATIONSHIP
    * ONLY ONE OF MEASURES IS TO BE IMPLEMENTED, WITH A MAXIMUM
VOLUME
OF EUR 8,000,000
    * IN OPINION OF BIOFRONTERA AG, ISSUE PRICE PROVIDED FOR
UNDER
AGENDA ITEM 2 IS ALSO NOT OBJECTIONABLE, ESPECIALLY SINCE
DISCOUNT ON STOCK MARKET PRICE ALSO APPEARS TO BE CUSTOMARY AND
APPROPRIATE IN MARKET, TAKING INTO ACCOUNT GENERAL CONDITIONS,
IN PARTICULAR VOLATILE MARKETS AS A RESULT OF TURNAROUND IN
INTEREST RATES AND UKRAINE CRISIS
    * PROPOSED RESOLUTIONS WERE ADOPTED BY EXECUTIVE BOARD AND
SUPERVISORY BOARD IN ACCORDANCE WITH LEGAL REQUIREMENTS AND NOT
BY A SINGLE SHAREHOLDER

Source text for Eikon:  ID:nPexPwdc2a 
Further company coverage:  B8FGn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))